THE HAGUE, Oct. 11 (Xinhua) -- Rabobank cycling team did not give a detailed reaction on Thursday to the doping confession of their former cyclist Levi Leipheimer in the report on the structural use of doping in the former US Postal/USPS cycling team by the United States Anti Doping Agency (USADA).
In the report the now 38-year-old Leipheimer confessed to have used doping for years, not only as teammate of Lance Armstrong, but also between 2002 and 2004, when he was employed by the Dutch Rabobank team. In his confession he also said that he was assisted by the team doctor in inflicting and buying EPO and that he knew one other teammate was doing the same.
"The Rabobank Cycling Team's management has been informed of the results of the USADA report and the confession made by Levi Leipheimer," the Dutch stated in a press release. "These testimonies confirm that cycling still faces difficult times, especially created by its past."
"The team's management would like to see that the world of cycling collectively closes the issue," the statement continued. "However, the problem appears to be so big that this should be done centrally. The sport of cycling has a huge past but in the meantime the sport also has a great future. The Rabobank Cycling Team is convinced the sport is heading in the right direction. The team's management looks towards the future. Rabobank wants to achieve results in cycling in a clean and fair manner."
On Wednesday the USADA published the report and according to the agency the evidence shows "beyond any doubt that the US Postal Service Pro Cycling Team ran the most sophisticated, professionalized and successful doping program that sport has ever seen".
The report of 1000 includes sworn testimony from 26 people, including 15 riders with knowledge of the US Postal team and its participants' doping activities.
The evidence also includes direct documentary evidence including financial payments, emails, scientific data and laboratory test results that allegedly further prove the use, possession and distribution of performance enhancing drugs by seven-time Tour de France winner Lance Armstrong.